Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms

Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+

Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837

The TNF and TNF Receptor Superfamilies

Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650

CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum

Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H., Stevens, J. L., & Ron, D. (1998) · Genes & Development · doi:10.1101/gad.12.7.982 · Cited by 2,014

Gadd153 Sensitizes Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the Cellular Redox State

McCullough, K. D., Martindale, J. L., Klotz, L.-O., Aw, T.-Y., & Holbrook, N. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1249-1259.2001 · Cited by 1,889

Organelle-specific initiation of cell death pathways

Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,456

Cross-Talk between Two Cysteine Protease Families

Nakagawa, T., & Yuan, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.4.887 · Cited by 1,168

REGULATION OF GENE EXPRESSION BY REACTIVE OXYGEN

Dalton, T. P., Shertzer, H. G., & Puga, A. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.67 · Cited by 1,118

Dissociable Deficits in the Decision-Making Cognition of Chronic Amphetamine Abusers, Opiate Abusers, Patients with Focal Damage to Prefrontal Cortex, and Tryptophan-Depleted Normal Volunteers Evidence for Monoaminergic Mechanisms

Rogers, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00091-8 · Cited by 1,101

Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers

Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984

DNA Repair, Genome Stability, and Aging

Lombard, D. B., Chua, K. F., Mostoslavsky, R., Franco, S., Gostissa, M., & Alt, F. W. (2005) · Cell · doi:10.1016/j.cell.2005.01.028 · Cited by 944

Non‐medical use of prescription stimulants among US college students: prevalence and correlates from a national survey

McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.00944.x · Cited by 884

Amphetamine: Effects on Catecholamine Systems and Behavior

Seiden, L. S., Sabol, K. E., & Ricaurte, G. A. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.003231 · Cited by 827

Fas Ligand-Induced Apoptosis

Nagata, S. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.29 · Cited by 779

Role of Microglia in Central Nervous System Infections

Rock, R. B., Gekker, G., Hu, S., Sheng, W. S., Cheeran, M., Lokensgard, J. R., & Peterson, P. K. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.942-964.2004 · Cited by 723

Oxidative Stress and Cell Signalling

Poli, G., Leonarduzzi, G., Biasi, F., & Chiarpotto, E. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365323 · Cited by 722

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport

Sulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688

Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings

McCann, U., Szabo, Z., Scheffel, U., Dannals, R., & Ricaurte, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04329-3 · Cited by 660

Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602 · cited 4×

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542

Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain

Sapp, E., Kegel, K. B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P. G., Vonsattel, J. P., & Difiglia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.161 · Cited by 540

Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

Schmidt, C. J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22673-8 · Cited by 529

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

Wagner, G. C., Ricaurte, G. A., Seiden, L. S., Schuster, C. R., Miller, R. J., & Westley, J. (1980) · Brain Research · doi:10.1016/0006-8993(80)91265-2 · Cited by 523

Invited Review Free radicals and the pathobiology of brain dopamine systems

Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499

Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity

Sonsalla, P. K., Nicklas, W. J., & Heikkila, R. E. (1989) · Science · doi:10.1126/science.2563176 · Cited by 490

Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study

Ricaurte, G. A., Schuster, C. R., & Seiden, L. S. (1980) · Brain Research · doi:10.1016/0006-8993(80)90952-x · Cited by 490

Mitochondria, the killer organelles and their weapons

Ravagnan, L., Roumier, T., & Kroemer, G. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10111 · Cited by 483

Cytotoxic and genotoxic potential of dopamine

Stokes, A. H., Hastings, T. G., & Vrana, K. E. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6<659::aid-jnr1>3.0.co;2-c · Cited by 469

Transcription-independent pro-apoptotic functions of p53

Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

Battaglia, G., Yeh, S. Y., O'Hearn, E., Molliver, M. E., Kuhar, M. J., & De Souza, E. B. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39191-3 · Cited by 458

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Commins, D. L., Vosmer, G., Virus, R. M., Woolverton, W. L., Schuster, C. R., & Seiden, L. S. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00317-9 · Cited by 453

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress

Cubells, J., Rayport, S., Rajendran, G., & Sulzer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448

Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine

LaVoie, M. J., & Hastings, T. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 447

Profiles of Cognitive Dysfunction in Chronic Amphetamine and Heroin Abusers

Ornstein, T. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00097-x · Cited by 427

The CD95 Type I/Type II model

Barnhart, B. C., Alappat, E. C., & Peter, M. E. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00031-9 · Cited by 419

Further studies of the role of hyperthermia in methamphetamine neurotoxicity.

Bowyer, J. F., Davies, D. L., Schmued, L., Broening, H. W., Newport, G. D., Slikker, W., & Holson, R. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38650-7 · Cited by 411

Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET

Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1206 · Cited by 406

p53 in neuronal apoptosis

Culmsee, C., & Mattson, M. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.149 · Cited by 389

Mood Disturbances and Regional Cerebral Metabolic Abnormalities inRecently Abstinent Methamphetamine Abusers

London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., Shinn, A. K., Miotto, K., Learn, J., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 384

Intracellular Ca2+-dependent protease (CALPAIN) and its high-molecular-weight endogenous inhibitor (CALPASTATIN)

Murachi, T., Tanaka, K., Hatanaka, M., & Murakami, T. (1981) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(81)90026-1 · Cited by 374

Memory impairment in abstinent MDMA ("Ecstasy") users

Bolla, K. I., McCann, U. D., & Ricaurte, G. A. (1998) · Neurology · doi:10.1212/wnl.51.6.1532 · Cited by 373

Chapter 15 Nitric oxide in neurodegeneration

(1998) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63210-0 · Cited by 372

Sick Chaperones, Cellular Stress, and Disease

Macario, A. J. L., & de Macario, E. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050111 · Cited by 372

Glutamate neurotoxicity, oxidative stress and mitochondria

Atlante, A., Calissano, P., Bobba, A., Giannattasio, S., Marra, E., & Passarella, S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02437-1 · Cited by 360

Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1

Imai, Y., & Kohsaka, S. (2002) · Glia · doi:10.1002/glia.10149 · Cited by 359

Mechanisms of neural plasticity following brain injury

Wieloch, T., & Nikolich, K. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.011 · Cited by 349

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

Stone, D. M., Stahl, D. C., Hanson, G. R., & Gibb, J. W. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90555-8 · Cited by 346

Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05096.1999 · Cited by 339

Microglial cell population dynamics in the injured adult central nervous system

Ladeby, R., Wirenfeldt, M., Garcia-Ovejero, D., Fenger, C., Dissing-Olesen, L., Dalmau, I., & Finsen, B. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.009 · Cited by 334

Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.15 · Cited by 332

TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.

Krieglstein, K., Suter-Crazzolara, C., Fischer, W. H., & Unsicker, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07052.x · Cited by 324

Cognitive Impairment in Individuals Currently Using Methamphetamine

Simon, S. L., Domier, C., Carnell, J., Brethen, P., Rawson, R., & Ling, W. (2000) · The American Journal on Addictions · doi:10.1080/10550490050148053 · Cited by 321

Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine Administration

Ellison, G., Eison, M. S., Huberman, H. S., & Daniel, F. (1978) · Science · doi:10.1126/science.26975 · Cited by 312

MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons

Battaglia, G., Yeh, S. Y., & De Souza, E. B. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90155-4 · Cited by 312

(±3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates

Ricaurte, G. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410010059035 · Cited by 300

Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999) · Psychopharmacology · doi:10.1007/s002130050967 · Cited by 300

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

Schmidt, C. J., Levin, J. A., & Lovenberg, W. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90729-5 · Cited by 297

Brain Temperature Alters Hydroxyl Radical Production during Cerebral Ischemia/Reperfusion in Rats

Kil, H. Y., Zhang, J., & Piantadosi, C. A. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00012 · Cited by 291

The Infant Development, Environment, and Lifestyle Study: Effects of Prenatal Methamphetamine Exposure, Polydrug Exposure, and Poverty on Intrauterine Growth

Smith, L. M., LaGasse, L. L., Derauf, C., Grant, P., Shah, R., Arria, A., Huestis, M., Haning, W., Strauss, A., Grotta, S. D., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-2564 · Cited by 290

Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers

Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.90 · Cited by 287

Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis

Cadet, J. L., Jayanthi, S., & Deng, X. (2003) · The FASEB Journal · doi:10.1096/fj.03-0073rev · Cited by 286

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users

Semple, D. M., Ebmeier, K. P., Glabus, M. F., O'Carroll, R. E., & Johnstone, E. C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.63 · Cited by 280

Methamphetamine induces neuronal apoptosis via cross‐talks between endoplasmic reticulum and mitochondria‐dependent death cascades

Jayanthi, S., Deng, X., H. Noailles, P., Ladenheim, B., & Lud Cadet, J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0295com · Cited by 278

Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses

Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270

Methamphetamine-induced neuronal damage: A possible role for free radicals

De Vito, M. J., & Wagner, G. C. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90130-5 · Cited by 270

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

Fischer, C., Hatzidimitriou, G., Wlos, J., Katz, J., & Ricaurte, G. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05476.1995 · Cited by 268

Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter

Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266

Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.

Miller, D. B., & O'Callaghan, J. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22434-x · Cited by 259

Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.

Albers, D. S., & Sonsalla, P. K. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12160-5 · Cited by 256

Neurotoxicity of MDMA and Related Compounds: Anatomic Studiesa

MOLLIVER, M. E., BERGER, U. V., MAMOUNAS, L. A., MOLLIVER, D. C., O'HEARN, E., & WILSON, M. A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16916.x · Cited by 252

Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions

Gudelsky, G. A., & Nash, J. F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010243.x · Cited by 251

Higher Cortical and Lower Subcortical Metabolism in Detoxified Methamphetamine Abusers

Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., Wong, C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.383 · Cited by 249

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) are attenuated by the serotonin uptake inhibitor citalopram

Liechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248

Neurotransmitter transporters and their impact on the development of psychopharmacology

Iversen, L. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706428 · Cited by 243

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α

Sriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242 · cited 1×

Association of Dopamine Transporter Loss in the Orbitofrontal and Dorsolateral Prefrontal Cortices With Methamphetamine-Related Psychiatric Symptoms

Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1699 · Cited by 241

Nucleotide excision repair: From E. coli to man

Petit, C., & Sancar, A. (1999) · Biochimie · doi:10.1016/s0300-9084(99)80034-0 · Cited by 231

DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation

Li, Y., & Trush, M. A. (1993) · Carcinogenesis · doi:10.1093/carcin/14.7.1303 · Cited by 227

Like cops on the beat: the active role of resting microglia

Raivich, G. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.09.001 · Cited by 225

Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis

Jayanthi, S., Deng, X., Ladenheim, B., McCoy, M. T., Cluster, A., Cai, N.-S., & Cadet, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404990102 · Cited by 223

The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats

Mechan, A. O., Esteban, B., O'Shea, E., Elliott, J. M., Colado, M. I., & Green, A. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704442 · Cited by 221

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

Gordon, C. J., Watkinson, W. P., O'Callaghan, J. P., & Miller, D. B. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90288-d · Cited by 220

Current concepts in apoptosis: The physiological suicide program revisited

Chowdhury, I., Tharakan, B., & Bhat, G. (2006) · Cellular and Molecular Biology Letters · doi:10.2478/s11658-006-0041-3 · Cited by 216

High-Dose Methamphetamine Acutely Activates the Striatonigral Pathway to Increase Striatal Glutamate and Mediate Long-Term Dopamine Toxicity

Mark, K. A., Soghomonian, J.-J., & Yamamoto, B. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3597-04.2004 · Cited by 215

Roles of activin in tissue repair, fibrosis, and inflammatory disease

WERNER, S., & ALZHEIMER, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.001 · Cited by 209

Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity

LaVoie, M. J., Card, J. P., & Hastings, T. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.010 · Cited by 204

Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue

Schmidt, C. J., Wu, L., & Lovenberg, W. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90140-8 · Cited by 202

Molecular mechanisms of DNA mismatch repair

Hsieh, P. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(01)00088-x · Cited by 202

Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms

Lyles, J., & Cadet, J. L. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00173-5 · Cited by 199

Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method

Deng, X., Wang, Y., Chou, J., & Cadet, J. L. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00184-x · Cited by 199

Base excision repair in a network of defence and tolerance

Nilsen, H., & Krokan, H. E. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.987 · Cited by 196

The Use, Misuse and Diversion of Prescription Stimulants Among Middle and High School Students

McCabe, S. E., Teter, C. J., & Boyd, C. J. (2004) · Substance Use & Misuse · doi:10.1081/ja-120038031 · Cited by 195

Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines

Thomas, D. M., Dowgiert, J., Geddes, T. J., Francescutti-Verbeem, D., Liu, X., & Kuhn, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.065 · Cited by 193

Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy"): Preliminary Findings

Reneman, L., Lavalaye, J., Schmand, B., de Wolff, F. A., van den Brink, W., den Heeten, G. J., & Booij, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.901 · Cited by 191

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies

McCann, U. D., Eligulashvili, V., & Ricaurte, G. A. (2000) · Neuropsychobiology · doi:10.1159/000026665 · Cited by 190

Integrin signaling in epithelial cells

Gilcrease, M. Z. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.03.031 · Cited by 190

Seizures associated with recreational drug abuse

Alldredge, B. K., Lowenstein, D. H., & Simon, R. P. (1989) · Neurology · doi:10.1212/wnl.39.8.1037 · Cited by 185

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat

Stone, D. M., Merchant, K. M., Hanson, G. R., & Gibb, J. W. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90117-1 · Cited by 183

Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

McKenna, D. J., & Peroutka, S. J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13277.x · Cited by 183

THE EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA, “ECSTASY”) ON MONOAMINERGIC NEUROTRANSMISSION IN THE CENTRAL NERVOUS SYSTEM

WHITE, S. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00027-5 · Cited by 180

Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.

Nash, J. F., Meltzer, H. Y., & Gudelsky, G. A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24086-1 · Cited by 179

Amphetamines induce apoptosis and regulation of bcl‐x splice variants in neocortical neurons

Stumm, G., Schlegel, J., Schäfer, T., Würz, C., Mennel, H. D., Krieg, J. ‐., & Vedder, H. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1065 · Cited by 177

Patterns of Methamphetamine Abuse and Their Consequences

Cho, A. K., & Melega, W. P. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_03 · Cited by 166

Methamphetamine causes differential regulation of pro‐death and anti‐death Bcl‐2 genes in the mouse neocortex

JAYANTHI, S., DENG, X., BORDELON, M., MCCOY, M. T., & CADET, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.01-0025com · Cited by 165

3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.

Insel, T. R., Battaglia, G., Johannessen, J. N., Marra, S., & De Souza, E. B. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23487-5 · Cited by 162

Amphetamine toxicity: Experience with 127 cases

Derlet, R. W., Rice, P., Horowitz, B. Z., & Lord, R. V. (1989) · Journal of Emergency Medicine · doi:10.1016/0736-4679(89)90263-1 · Cited by 154

Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

Gluck, M. R., Moy, L. Y., Jayatilleke, E., Hogan, K. A., Manzino, L., & Sonsalla, P. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00549.x · Cited by 153

Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states

Paschen, W. (2001) · Cell Calcium · doi:10.1054/ceca.2000.0162 · Cited by 151

Uncoupling the agony from ecstasy

Mills, E., Banks, M. L., Sprague, J. E., & Finkel, T. (2003) · Nature · doi:10.1038/426403a · Cited by 151

Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens

Abekawa, T., Ohmori, T., & Koyama, T. (1994) · Brain Research · doi:10.1016/0006-8993(94)90033-7 · Cited by 149

Selective Blockade of mGlu5 Metabotropic Glutamate Receptors Is Protective against Methamphetamine Neurotoxicity

Battaglia, G., Fornai, F., Busceti, C. L., Aloisi, G., Cerrito, F., Blasi, A. D., Melchiorri, D., & Nicoletti, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02135.2002 · Cited by 148

Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

Malberg, J. E., Sabol, K. E., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20131-8 · Cited by 147

3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotonin Receptor Function and Serotonin-Dopamine Interactions

Bankson, M. G., & Cunningham, K. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29607-5 · Cited by 145

Resistance of Neuronal Nitric Oxide Synthase-Deficient Mice to Methamphetamine-Induced Dopaminergic Neurotoxicity

Itzhak, Y., Gandia, C. E., Huang, P. L., & Ali, S. F. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37339-2 · Cited by 145

In vivo detection of short- and long-term MDMA neurotoxicity?a positron emission tomography study in the living baboon brain

Scheffel, U., Szabó, Z. R., Mathews, W. B., Finley, P. A., Dannals, R. F., Ravert, H. T., Szabo, K., Yuan, J., & Ricaurte, G. A. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199806)29:2<183::aid-syn9>3.0.co;2-3 · Cited by 143

Methamphetamine‐Induced Changes in Antioxidant Enzymes and Lipid Peroxidation in Copper/Zinc‐Superoxide Dismutase Transgenic Mice

Jayanthi, S., Ladenheim, B., & Cadet, J. L. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08224.x · Cited by 141

Amphetamine psychosis and psychotic symptoms

Janowsky, D. S., & Risch, C. (1979) · Psychopharmacology · doi:10.1007/bf00491982 · Cited by 140

Psychophysiological Aspects of Amphetamine-Methamphetamine Abuse

Murray, J. B. (1998) · The Journal of Psychology · doi:10.1080/00223989809599162 · Cited by 140

Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation

Imam, S. Z., & Ali, S. F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02249-0 · Cited by 138

Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine

Fukami, G., Hashimoto, K., Koike, K., Okamura, N., Shimizu, E., & Iyo, M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.072 · Cited by 137

Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans

Gerra, G., Zaimovic, A., Ferri, M., Zambelli, U., Timpano, M., Neri, E., Marzocchi, G. F., Delsignore, R., & Brambilla, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00180-8 · Cited by 136

Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review

Cadet, J. L., Jayanthi, S., & Deng, X. (2005) · Neurotoxicity Research · doi:10.1007/bf03033973 · Cited by 135

Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.

Scanzello, C. R., Hatzidimitriou, G., Martello, A. L., Katz, J. L., & Ricaurte, G. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10168-7 · Cited by 135

Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate

Wagner, C., Ricaurte, G. A., Johanson, C. E., Schuster, C. R., & Seiden, L. S. (1980) · Neurology · doi:10.1212/wnl.30.5.547 · Cited by 134

MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity

Thomas, D. M., & Kuhn, D. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.049 · Cited by 134

5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

Colado, M. I., Murray, T. K., & Green, A. R. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12846.x · Cited by 132

Methamphetamine induces apoptosis in immortalized neural cells: Protection by the Proto-Oncogene, bcl-2

Cadet, J. L., Ordonez, S., & Ordóñez, J. V. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199702)25:2<176::aid-syn8>3.0.co;2-9 · Cited by 130

Death in amphetamine users: causes and rates.

Kalant, H., & Kalant, O. J. (1975) · PubMed Central · Cited by 129

Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing

Dafters, R. I. (1995) · Physiology & Behavior · doi:10.1016/0031-9384(95)00136-7 · Cited by 129

Molecular chaperones, stress proteins and redox homeostasis

Papp, E., Nardai, G., Sőti, C., & Csermely, P. (2003) · BioFactors · doi:10.1002/biof.5520170124 · Cited by 124

Hyperthermia in Psychostimulant Overdose

Callaway, C. W., & Clark, R. F. (1994) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(94)70165-2 · Cited by 124

A Potential Role for Cyclized Quinones Derived from Dopamine, DOPA, and 3,4-Dihydroxyphenylacetic Acid in Proteasomal Inhibition

Zafar, K. S., Siegel, D. M., & Ross, D. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024703 · Cited by 124

Upregulation of the Fas Receptor Death-Inducing Signaling Complex after Traumatic Brain Injury in Mice and Humans

Qiu, J., Whalen, M. J., Lowenstein, P. R., Fiskum, G. M., Fahy, B. G., Darwish, R., Aarabi, B., Yuan, J., & Moskowitz, M. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03504.2002 · Cited by 124

Amphetamine Intoxication with Coagulopathy, Hyperthermia, and Reversible Renal Failure

Ginsberg, M. D., HERTZMAN, M., & SCHMIDT-NOWARA, W. W. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-1-81 · Cited by 122

Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’)

Ricaurte, G. A., McCann, U., Szabò, Z., & Scheffel, U. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00216-7 · Cited by 122

Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway

Deng, X., Cai, N.-S., McCoy, M. T., Chen, W., Trush, M. A., & Cadet, J. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00034-5 · Cited by 121

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

Kish, S. J., Furukawa, Y., Ang, L.-C., Vorce, S. P., & Kalasinsky, K. S. (2000) · Neurology · doi:10.1212/wnl.55.2.294 · Cited by 119

Methamphetamine neurotoxicity: Dissociation of striatal dopamine terminal damage from parietal cortical cell body injury

Eisch, A. J., & Marshall, J. F. (1998) · Synapse · Cited by 118

Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice

Hirata, H., Ladenheim, B., Carlson, E. J., Epstein, C. J., & Cadet, J. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01502-7 · Cited by 117

Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region

Farrell, M., Marsden, J., Ali, R. L., & Ling, W. W. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00195.x · Cited by 116

Null Mutation of c-fos Causes Exacerbation of Methamphetamine-Induced Neurotoxicity

Deng, X., Ladenheim, B., Tsao, L.-I., & Cadet, J. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-10107.1999 · Cited by 113

Peroxynitrite plays a role in methamphetamine‐induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper–zinc superoxide dismutase

Imam, S. Z., Newport, G. D., Itzhak, Y., Cadet, J. L., Islam, F., Slikker, W., & Ali, S. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00029.x · Cited by 111

Methamphetamine‐induced dopaminergic neurotoxicity is regulated by quinone formation‐related molecules

Miyazaki, I., Asanuma, M., Diaz-Corrales, F. J. J., Fukuda, M., Kitaichi, K., Miyoshi, K., & Ogawa, N. (2006) · The FASEB Journal · doi:10.1096/fj.05-4996fje · Cited by 111

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA)

Slikker, W., Ali, S. F., Scallet, A. C., Frith, C. H., Newport, G. D., & Bailey, J. (1988) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(88)90285-2 · Cited by 110

Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.

Farfel, G. M., & Seiden, L. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24411-1 · Cited by 110

Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan.

Farfel, G. M., & Seiden, L. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24505-0 · Cited by 108

Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.

Sabol, K. E., Lew, R., Richards, J. B., Vosmer, G. L., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12371-9 · Cited by 106

The spin trap reagent α-phenyl-N-tert-butylnitrone prevents ‘ecstasy’-induced neurodegeneration of 5-hydroxytryptamine neurones

Colado, M. I., & Green, A. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00298-y · Cited by 105

Temporal profiling of methamphetamine‐induced changes in gene expression in the mouse brain: Evidence from cDNA array

Cadet, J. L., Jayanthi, S., McCoy, M. T., Vawter, M. P., & Ladenheim, B. (2001) · Synapse · doi:10.1002/syn.1058 · Cited by 103

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observationsa

Ricaurte, G. A., Finnegan, K. T., Irwin, I., & Langston, J. W. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16919.x · Cited by 102

Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers

Gustavsen, I., Mørland, J. G., & Bramness, J. G. (2005) · Accident Analysis & Prevention · doi:10.1016/j.aap.2005.11.005 · Cited by 101

Microglia Activation in the Brain as Inflammatory Biomarker of Alzheimer’s Disease Neuropathology and Clinical Dementia

Xiang, Z., Haroutunian, V., Ho, L., Purohit, D., & Pasinetti, G. M. (2006) · Disease Markers · doi:10.1155/2006/276239 · Cited by 101

Toxic Effects of Opioid and Stimulant Drugs on Undifferentiated PC12 Cells

OLIVEIRA, M. T., Rego, A. C., Morgadinho, M. T., Macedo, T. R. A., & Oliveira, C. R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04190.x · Cited by 99

Regulation of Bcl-2 proteins during anoikis and amorphosis

Martin, S. S., & Vuori, K. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.02.008 · Cited by 98

Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization

Yui, K., Goto, K., Ikemoto, S., Ishiguro, T., Angrist, B., Duncan, G. E., Sheitman, B., Lieberman, J. A., Bracha, S., & Ali, S. F. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000575 · Cited by 95

Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy)

Sprague, J. E., Banks, M. L., Cook, V. J., & Mills, E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044982 · Cited by 95

Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia

Bartu, A. E., Freeman, N. C., Gawthorne, G. S., Codde, J., & Holman, C. D. J. (2003) · Addiction · doi:10.1111/j.1360-0443.2004.00602.x · Cited by 95

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA)

Cadet, J. L., Ladenheim, B., Baum, I., Carlson, E. J., & Epstein, C. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91624-1 · Cited by 93

Dopamine-glutamate interactions in methamphetaminc-induced neurotoxicity

Marshall, J. F., O’Dell, S. J., & Weihmuller, F. B. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245234 · Cited by 93

Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users: Preliminary Observations

Price, L. H., Ricaurte, G. A., Krystal, J. H., & Heninger, G. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010022003 · Cited by 93

Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.

Lew, R., Sabol, K. E., Chou, C., Vosmer, G. L., Richards, J. B., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12372-0 · Cited by 93

Clinical manifestations and prognostic features of acute methamphetamine intoxication.

Lan, K. C., Lin, Y., Yu, F. C., Lin, C. S., & Chu, P. (1998) · PubMed · Cited by 91

Neuropeptide Y Protects against Methamphetamine-Induced Neuronal Apoptosis in the Mouse Striatum

Thiriet, N., Deng, X., Solinas, M., Ladenheim, B., Curtis, W., Goldberg, S. R., Palmiter, R. D., & Cadet, J. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4893-04.2005 · Cited by 91

The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells

Simantov, R., & TAUBER, M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039956 · Cited by 89

Methamphetamine-induced apoptosis is attenuated in the striata of copper–zinc superoxide dismutase transgenic mice

Deng, X., & Cadet, J. L. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00169-8 · Cited by 89

Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy)

Jayanthi, S., Ladenheim, B., Andrews, A. M., & Cadet, J. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00698-8 · Cited by 89

Elevation of Ambient Room Temperature has Differential Effects on MDMA-Induced 5-HT and Dopamine Release in Striatum and Nucleus Accumbens of Rats

O’Shea, E., Escobedo, I., Orío, L., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300673 · Cited by 87

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

Ricaurte, G. A., DeLanney, L. E., Wiener, S. G., Irwin, I., & Langston, J. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)90451-9 · Cited by 87

Attention and memory in illicit amphetamine users

McKetin, R., & Mattick, R. P. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00132-4 · Cited by 86

Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease

Hughes, P. E., Alexi, T., Williams, C. E., CLARK, R. G., & Gluckman, P. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00724-6 · Cited by 85

Driving Under the Influence of Drugs in Sweden with Zero Concentration Limits in Blood for Controlled Substances

Jones, A. W. (2005) · Traffic Injury Prevention · doi:10.1080/15389580500253760 · Cited by 85

Neurotoxicity of MDMA: Neurochemical Effects

SCHMID, C. J., & Kehne, J. H. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16917.x · Cited by 84

Are Risk and Protective Factors for Substance Use Consistent Across Historical Time?: National Data From the High School Classes of 1976 Through 1997

Brown, T. N., Schulenberg, J., Bachman, J. G., O'Malley, P. M., & Johnston, L. D. (2001) · Prevention Science · doi:10.1023/a:1010034912070 · Cited by 82

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine

Schmidt, C. J., Black, C. K., & Taylor, V. L. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90245-2 · Cited by 82

Fatal poisoning in Nordic drug addicts in 2002

Steentoft, A., Teige, B., Holmgren, P., Vuori, E., Kristinsson, J., Hansen, A. C., Ceder, G., Wethe, G., & Rollmann, D. (2005) · Forensic Science International · doi:10.1016/j.forsciint.2005.09.004 · Cited by 81

Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats.

Wagner, G. C., Carelli, R. M., & Jarvis, M. F. (1985) · PubMed · Cited by 80

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic mice

Cadet, J. L., Ladenheim, B., Hirata, H., Rothman, R. B., Ali, S. F., Carlson, E. J., Epstein, C. J., & Moran, T. H. (1995) · Synapse · doi:10.1002/syn.890210210 · Cited by 79

Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug

Asanuma, M., Tsuji, T., Miyazaki, I., Miyoshi, K., & Ogawa, N. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.015 · Cited by 78

Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)

Paris, J. M., & Cunningham, K. A. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90237-r · Cited by 75

Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria‐dependent pathway

Krasnova, I. N., Ladenheim, B., & Cadet, J. L. (2005) · The FASEB Journal · doi:10.1096/fj.04-2881fje · Cited by 74

Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*

Sprague, J. E., Moze, P., Caden, D., Rusyniak, D. E., Holmes, C. S., Goldstein, D. S., & Mills, E. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000165969.29002.70 · Cited by 73

Nitric oxide, S-nitrosylation and neurodegeneration.

Chung, K. K. K., Dawson, T. M., & Dawson, V. L. (2005) · PubMed · Cited by 73

Effect of 3,4-Methylenedioxymethamphetamine (MDMA) on Hippocampal Dopamine and Serotonin

Shankaran, M., & Gudelsky, G. A. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00103-8 · Cited by 71

Egr Family Members Regulate Nonlymphoid Expression of Fas Ligand, TRAIL, and Tumor Necrosis Factor during Immune Responses

Droin, N. M., Pinkoski, M. J., Dejardin, E., & Green, D. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7638-7647.2003 · Cited by 70

Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation

Li‐Weber, M., Laur, O., & Krammer, P. H. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<3017::aid-immu3017>3.0.co;2-r · Cited by 68

Hyperthermia Enhances the Cytotoxic Effects of Reactive Oxygen Species to Chinese Hamster Cells and Bovine Endothelial Cells in Vitro

Lin, P.-S., Quamo, S., Ho, K.-C., & Gladding, J. (1991) · Radiation Research · doi:10.2307/3578169 · Cited by 67

Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs

Itzhak, Y., & Ali, S. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.004 · Cited by 67

Striatal dopamine releasein vivofollowing neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine

Baldwin, H. A., Colado, M. I., Murray, T. K., Souza, R. J. D., & Green, A. R. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12847.x · Cited by 67

Nitric oxide‐dependent damage to neuronal mitochondria involves the NMDA receptor

Stewart, V. C., Heslegrave, A., Brown, G. C., Clark, J. B., & Heales, S. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01878.x · Cited by 67

Erratum

(2005) · Addiction · doi:10.1111/j.1360-0443.2005.01096.x · Cited by 67

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine

Dafters, R. I., & Lynch, E. (1998) · Psychopharmacology · doi:10.1007/s002130050664 · Cited by 66

Intracerebral haemorrhage and vasculitis secondary to amphetamine use

Salanova, V., & Taubner, R. (1984) · Postgraduate Medical Journal · doi:10.1136/pgmj.60.704.429 · Cited by 65

Bromocriptine Scavenges Methamphetamine‐induced Hydroxyl Radicals and Attenuates Dopamine Depletion in Mouse Striatuma

Kondo, T., Ito, T., & SUGITA, Y. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21807.x · Cited by 63

nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice

Itzhak, Y., Martin, J. L., & Ali, S. F. (2000) · Neuroreport · doi:10.1097/00001756-200009110-00022 · Cited by 63

Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PET

Buchert, R., Obrocki, J., Thomasius, R., Vaeterlein, O., Petersen, K. U., Jenicke, L., Bohuslavizki, K. H., & Clausen, M. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200108000-00007 · Cited by 63

A study of the mechanism of MDMA (‘Ecstasy’)‐induced neurotoxicity of 5‐HT neurones using chlormethiazole, dizocilpine and other protective compounds

Colado, M. I., & Green, A. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14034.x · Cited by 62

Methamphetamine selectively alters brain glutathione

Harold, C., Wallace, T. L., Friedman, R., Gudelsky, G. A., & Yamamoto, B. K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00392-7 · Cited by 62

Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.

Clausing, P., Gough, B., Holson, R. R., Slikker, W., & Bowyer, J. F. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10562-4 · Cited by 61

Chronic Psychotic Illness From Methamphetamine

Buffenstein, A., HEASTER, J., & KO, P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.662 · Cited by 60

Glutamatergic substrates of drug addiction and alcoholism

Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484

Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Clark, K. H., Wiley, C. A., & Bradberry, C. W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9334-7 · Cited by 194

Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin

Gonçalves, J., Baptista, S., Martins, T., Milhazes, N., Borges, F., Ribeiro, C. F., Malva, J. O., & Silva, A. P. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07059.x · Cited by 152

Lipopolysaccharide mitagates methamphetamine-induced striatal dopamine depletion via modulating local TNF-α and dopamine transporter expression

Lai, Y.-T., Tsai, Y.-P. N., Cherng, C. G., Ke, J.-J., Ho, M.-C., Tsai, C.-W., & Yu, L. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0204-2 · Cited by 29